Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for hepatitis C vaccine

A J Zuckerman1, J N Zuckerman

  • 1WHO Collaborating Centre for Reference and Research on Viral Diseases, Royal Free Hospital and School of Medicine, London, U.K.

Journal of Hepatology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selected Sumaries.

Acta clinica Belgica·2016
Same author

Viral hepatitis and haemophilia: an introduction.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

A study to assess the immunogenicity, reactogenicity and safety of hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Trials of Live Influenza Vaccine in the Royal Air Force.

British medical journal·2010
Same author

ABO Blood Groups and Acute Respiratory Virus Disease.

British medical journal·2010
Same author

Acute hepatitis.

British medical journal·2010

Developing a broad-spectrum hepatitis C vaccine is challenging due to viral heterogeneity and reinfections. Key steps include identifying neutralizing antibodies and improving tissue culture techniques for hepatitis C virus (HCV).

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Hepatitis C virus (HCV) exhibits significant genetic and serological diversity.
  • Viral reinfections pose a challenge to achieving long-term immunity.
  • Existing challenges hinder the development of a universal HCV vaccine.

Purpose of the Study:

  • To outline critical steps for developing a broad-spectrum hepatitis C vaccine.
  • To address the complexities posed by HCV heterogeneity and reinfection.

Main Methods:

  • Identification of broadly neutralizing antibodies against HCV.
  • Development of reproducible tissue culture methods for HCV.
  • Adaptation of vaccine development strategies from related viruses like flaviviruses and pestiviruses.

Related Experiment Videos

  • Application of gene transfer techniques for vaccine design.

    • Main Results:

    • The study identifies key research areas crucial for HCV vaccine development.
    • It highlights the necessity of understanding viral heterogeneity to guide antibody identification.
    • Progress in tissue culture and gene transfer is essential for vaccine efficacy.

    Conclusions:

    • A broad-spectrum hepatitis C vaccine requires overcoming significant viral hurdles.
    • Targeting neutralizing antibodies and advancing culture techniques are paramount.
    • Leveraging existing vaccine technologies for related viruses is a promising approach.